Reverse Phase Protein Arrays for Compound Profiling
Authors:
- 13 September 2016
- journal article
- research article
- Published by Wiley in Current Protocols in Chemical Biology
- Vol. 8 (3) , 179-196
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Systematic analysis of BRAFV600E melanomas reveals a role for JNK/c‐Jun pathway in adaptive resistance to drug‐induced apoptosisMolecular Systems Biology, 2015
- Vemurafenib: the first drug approved for BRAF-mutant cancerNature Reviews Drug Discovery, 2012
- Profiling phospho-signaling networks in breast cancer using reverse-phase protein arraysOncogene, 2012
- Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling NetworksCell, 2012
- A Dual Array-Based Approach to Assess the Abundance and Posttranslational Modification State of Signaling ProteinsScience Signaling, 2012
- Narrative Review: BRAF Opens the Door for Therapeutic Advances in MelanomaAnnals of Internal Medicine, 2010
- A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast CancersClinical Proteomics, 2010
- Targeting the cancer kinome through polypharmacologyNature Reviews Cancer, 2010
- Collecting and organizing systematic sets of protein dataNature Reviews Molecular Cell Biology, 2006
- Profiling receptor tyrosine kinase activation by using Ab microarraysProceedings of the National Academy of Sciences, 2003